The relationship between plasma amino acid and anemia, prognosis in hemodialysis patients
Not Applicable
- Conditions
- end stage renal disease
- Registration Number
- JPRN-UMIN000023287
- Lead Sponsor
- Yokohama city university hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 141
Inclusion Criteria
Not provided
Exclusion Criteria
severe congestive heart failure (New York Heart Association class III or IV) uncontrolled hypertension (defined as a pre-dialysis diastolic blood pressure >110 mm Hg) acute malignancy major surgery within the previous 6 months active bleeding, need for erythrocyte transfusion within 12 weeks before the study systemic inflammatory disease and/or C-reactive protein levels >3 mg/d
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method plasma amino acid level complete blood count cardiovascular disease death - 4 years all cause death - 4 years
- Secondary Outcome Measures
Name Time Method